Literature DB >> 6728121

A compartmentalized, organ-cultured hypothalamo-neurohypophysial system for the study of vasopressin release.

C M Gregg, C D Sladek.   

Abstract

In the compartmentalized hypothalamo-neurohypophysial system ( CHNS ), a portion of medial basal hypothalamus (HT) containing the supraoptic nuclei (SON) and the neurohypophysis (PP) were organ-cultured in separate compartments. The intact axonal projections from SON to PP passed through a hole in a fluid-tight barrier which separated the two compartments. When properly sealed, the leak rate from one side to the other is less than 1%/24 h and the only connection between the 2 compartments is axonal. This system had relatively stable basal vasopressin (VP) release rates from both HT and PP for up to 72 h in culture. Basal neurohypophysial VP release rate was unchanged during two successive 1-hour periods on any given day. Physiological responsiveness was confirmed by osmotic challenge. When HT osmolality was changed by +/- 15 mosm, VP release from PP was appropriately and significantly increased or decreased. Equivalent changes in PP side osmolality had no effect on VP release. After 72 h in culture, the VP content of neural lobes from CHNS explants was more than double that of lobes which were severed from HT prior to culture. Finally, the presence of numerous VP neurophysin-containing cells in 72-hour cultured explants was demonstrated by immunocytochemistry. This system will be useful to localize sites of action for agents affecting VP release to either HT and/or PP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6728121     DOI: 10.1159/000123924

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  Multiple alpha1-adrenergic receptor subtypes support synergistic stimulation of vasopressin and oxytocin release by ATP and phenylephrine.

Authors:  Zhilin Song; Dayane A Gomes; Wanida Stevens; Celia D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-09-29       Impact factor: 3.619

2.  Role of fructose and fructokinase in acute dehydration-induced vasopressin gene expression and secretion in mice.

Authors:  Zhilin Song 宋志林; Carlos A Roncal-Jimenez; Miguel A Lanaspa-Garcia; Sarah A Oppelt; Masanari Kuwabara; Thomas Jensen; Tamara Milagres; Ana Andres-Hernando; Takuji Ishimoto; Gabriela E Garcia; Ginger Johnson; Paul S MacLean; Laura-Gabriela Sanchez-Lozada; Dean R Tolan; Richard J Johnson
Journal:  J Neurophysiol       Date:  2016-11-16       Impact factor: 2.714

Review 3.  An evolving story of angiotensin-II-forming pathways in rodents and humans.

Authors:  Carlos Maria Ferrario; Sarfaraz Ahmad; Sayaka Nagata; Stephen W Simington; Jasmina Varagic; Neal Kon; Louis Joseph Dell'italia
Journal:  Clin Sci (Lond)       Date:  2014-04       Impact factor: 6.124

4.  Sustained stimulation of vasopressin and oxytocin release by ATP and phenylephrine requires recruitment of desensitization-resistant P2X purinergic receptors.

Authors:  Dayane A Gomes; Zhilin Song; Wanida Stevens; Celia D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-22       Impact factor: 3.619

Review 5.  Estrogen receptors: their roles in regulation of vasopressin release for maintenance of fluid and electrolyte homeostasis.

Authors:  Celia D Sladek; Suwit J Somponpun
Journal:  Front Neuroendocrinol       Date:  2007-10-12       Impact factor: 8.606

6.  Supraoptic oxytocin and vasopressin neurons function as glucose and metabolic sensors.

Authors:  Zhilin Song; Barry E Levin; Wanida Stevens; Celia D Sladek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-01-29       Impact factor: 3.619

7.  The "metabolic sensor" function of rat supraoptic oxytocin and vasopressin neurons is attenuated during lactation but not in diet-induced obesity.

Authors:  Celia D Sladek; Wanida Stevens; Zhilin Song; Ginger C Johnson; Paul S MacLean
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-12-09       Impact factor: 3.619

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.